Search
Search
Reprogramming somatic cells to induced pluripotent stem cells is a critical and potentially time intensive step in your stem cell research. That’s why we offer choices in integration-free reprogramming technologies that fit your research and translational needs including our Cell Therapy Systems (CTS) Products, which are designed for clinical and translational research applications.
| Order | Order | Order | |
| Epi5 Episomal iPSC Reprogramming Kit* | CytoTune-iPS 2.0 Sendai Reprogramming Kit | CTS CytoTune-iPS 2.1 Sendai Reprogramming Kit | |
|---|---|---|---|
| Description | High-efficiency viral-free system requiring no small molecules | Highest efficiency integration-free reprogramming system | High-efficiency reprogramming system for clinical research |
| Reprogramming Efficiency | 0.04–0.3% | 0.02–1.2% | 0.01–0.6% |
| Genes utilized | Yamanaka factors +Lin28 | Yamanaka factors | Yamanaka factors Klf4, Oct4, Sox2 and L-myc |
| Training and expertise required | Moderate | Minimal | Minimal |
| Genomic integration-free | ✓ | ✓ | ✓ |
| Virus-free reprogramming | ✓ | ||
| Blood cell reprogramming | ✓ | ✓ | ✓ |
| Transfection products | Neon Transfection System or Lipofectamine 3000 | None | None |
| Reporter available | N/A | CytoTune-EmGFP Sendai Fluorescence Reporter | CytoTune-EmGFP Sendai Fluorescence Reporter |
*Designed by Dr. Okita in the laboratory of Professor Yamanaka at the Center for iPS Cell Research and Application (CiRA), Kyoto University.
Advances in Stem Cell Research Cell Reprogramming with Episomal iPSC Reprogramming Vectors
A Thought Leader's Perspective - Unlocking cardiovascular disease with iPS cells
For Research Use Only. Not for use in diagnostic procedures.